Ledger.Open graph →
SEC Form D · filed October 22, 2015

Audentes Therapeutics, Inc

Offering
$65.0M
Sold
$65.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Jonathan Silverstein · New York, NYDirectorThomas Schuetz · San Francisco, CADirectorKush Parmar · Menlo Park, CADirectorSteve Squinto · San Francisco, CADirectorJonathan Leff · New York, NYDirectorLouis G. Lange · San Francisco, CADirectorMatthew Patterson · San Francisco, CAExec · DirectorThomas Woiwode · Menlo Park, CADirectorRoy Carver, Jr · Fort Collins, CODirectorDaniel R. Omstead · San Diego, CADirectorCraig Kaplan · Capitola, CAExec · DirectorRichard P. Fox · Rochester, NYDirectorElai R. Davicioni · San Diego, CADirectorEd Neas · Fort Collins, CODirectorR. C. Pica · San Bruno, CADirectorDoug C. Pica · San Bruno, CADirectorSteven Waldman · Brooklyn, NYExec · DirectorJustis G. Kao · Studio City, CADirectorBenjamin Capell · Salt Lake City, UTDirectorTomas N. Tejero · Mexico DF, O5DirectorWilliam Nelson, V · Fort Collins, CODirectorSong Yi · Metairie, LADirectorThomas Woiwode · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗